Skip to main content

Scar Treatment Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Sales Forecast

Companies Profiled in the Scar Treatment Market are Smith + Nephew, Merz Pharma, Lumeins, Sientra Inc., Sonoma Pharmaceuticals Inc., Mölnlycke Health Care AB, Cynosure, CCA Industries Inc., Newmedical Technology Inc., Suneva Medical

Pune, India, Nov. 24, 2022 (GLOBE NEWSWIRE) — The global scar treatment market size is set to gain traction owing to rapid investments in cell-based research. Fortune Business InsightsTM has presented this information in its report titled “Scar Treatment Market, 2022-2029”. Scar revision is a method used to make scars appear more natural by making them blend in with the surrounding skin tone and texture.   

Industry Development –

August 2019: The Naval Medical University in China discusses the possibility of using minced split-thickness skin grafts with Pelnac as an overlay that may be effective for the reconstruction of full-thickness skin defects.


Get a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/scar-treatment-market-105608


Report Coverage –

The report exhaustive data on the scar treatment market industry. It covers segments like restraining and driving factors of the market, an overview of the R&D advancements in the scar treatment market. Furthermore, the report covers segments on the cumulative COVID-19 impact and key market players adopting several growth strategies like mergers and acquisitions to sustain through the incoming years.

Drivers & Restraints –

The Increasing Demand for Aesthetic Appearances to Augment Market Growth

One of the major factors driving scar treatment product demand is people’s growing concern about their aesthetic appearance. Road accidents, which can result in scars and other marks, are another important factor that contributes to market growth. Burn incidents have significantly increased over the years, and this is one of the primary reasons for the scar treatment market growth. However, the high cost of these new devices creates an affordability issue, which limits the global scar treatment market’s growth, particularly in developing countries.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/scar-treatment-market-105608


Regional Insights –

North America to Dominate the Global Market

The scar treatment market share is dominated by the region because of the high number of road accidents in North America. Rising disposable incomes, combined with increased spending on personal care products, will drive demand. The prevalence of skin disorders such as acne will benefit the growth of the regional industry.

A rise in the desire of the Latin American population to look beautiful and the high per capita expenditure on cosmetic procedures is expected to lead to rapid growth in the scar treatment market. Increased medical tourism for various cosmetic procedures would aid industry growth in the scar treatment market.

The Asia Pacific region is experiencing profitable growth, because of the presence of a huge population base with unfulfilled needs. Growing scar treatment awareness will also drive the industry’s growth in the region. Latin America, the Middle East & Africa are expected to grow during the forecast period, because of the expanded presence of prominent market players.

Competitive Landscape –

Key Players in the Market to Work on Inventing New Grafting Methods

Key players in the industry are focusing on inventing new methods of grafting and offering effective solutions in place of the traditional grafting methods. Merz Pharma, Sientra, Smith + Nephew, Lumeins, and others are some of the leading players in the industry.


Pre Book: https://www.fortunebusinessinsights.com/checkout-page/105608


Segmentation –

On the basis of product, the market is divided into injectable, laser, topical, and others. On the basis of type, the market is segmented into stretch marks, contractures, hypertrophic and keloids, and others. On the basis of end-user, the market is fragmented into specialty clinics, hospitals, and others. Geographically, the market is classified into Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa.       

Market Segmentation By Product

  • Topical
  • Laser
  • Injectable
  • Others
By Type

  • Hypertrophic and Keloids
  • Contractures
  • Stretch Marks
  • Others
By End User

  • Hospitals
  • Specialty Clinics
  • Others
By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


List of Key Players in the Global Market –

  • Smith + Nephew
  • Merz Pharma       
  • Lumeins
  • Sientra Inc.
  • Sonoma Pharmaceuticals Inc.
  • Mölnlycke Health Care AB
  • Cynosure
  • CCA Industries Inc.
  • Newmedical Technology Inc.
  • Suneva Medical


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/scar-treatment-market-105608


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

9th Floor, Icon Tower, Baner

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.

Phone:                  

U.S.:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.